VAQTA
NDC 0006-4095, hepatitis A vaccine, inactivated, injection, suspension, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-4095
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA103606
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)25 [iU]/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Hepatitis A Vaccines [CS]; Inactivated Hepatitis A Virus Vaccine [EPC]; Vaccines, Inactivated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0006-4095-02 | 00006409502 | 10 SYRINGE in 1 CARTON (0006-4095-02) / .5 mL in 1 SYRINGE (0006-4095-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0006-4095 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-4095. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.